ERBB2 and breast cancer: Considering the negative impact of ITCs and micro-metastases on prognosis in our cohort, our findings suggest that the need for serial sections and IHC examination of axillary lymph nodes may also apply to HER2-positive pT1a-b breast cancer to assist in the decision-making process regarding ACt.